Shandong Xinhua Pharmaceutical Company Limited (XIN.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 08:05AM CEST. Market open.
Currency in EUR
Valuation Measures4
| Market Cap (intraday) | 1.14B |
| Enterprise Value | 1.19B |
| Trailing P/E | 6.89 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.42 |
| Price/Book (mrq) | 0.70 |
| Enterprise Value/Revenue | 0.15 |
| Enterprise Value/EBITDA | 2.15 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change 3 | -11.27% |
| S&P500 52-Week Change 3 | 22.43% |
| 52 Week High 3 | 0.7700 |
| 52 Week Low 3 | 0.5500 |
| 50-Day Moving Average 3 | 0.6203 |
| 200-Day Moving Average 3 | 0.6302 |
Share Statistics
| Avg Vol (3 month) 3 | 162 |
| Avg Vol (10 day) 3 | N/A |
| Shares Outstanding 5 | 195M |
| Implied Shares Outstanding 6 | 1.81B |
| Float 8 | 403.14M |
| % Held by Insiders 1 | 10.68% |
| % Held by Institutions 1 | 1.58% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 0.03 |
| Forward Annual Dividend Yield 4 | 4.03% |
| Trailing Annual Dividend Rate 3 | 0.25 |
| Trailing Annual Dividend Yield 3 | 39.68% |
| 5 Year Average Dividend Yield 4 | 3.46 |
| Payout Ratio 4 | 28.53% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | Jul 07, 2023 |
| Last Split Factor 2 | 13:10 |
| Last Split Date 3 | Jul 06, 2018 |
Financial Highlights
Currency in CNY.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 6.13% |
| Operating Margin (ttm) | 6.93% |
Management Effectiveness
| Return on Assets (ttm) | 3.67% |
| Return on Equity (ttm) | 10.43% |
Income Statement
| Revenue (ttm) | 7.94B |
| Revenue Per Share (ttm) | 11.70 |
| Quarterly Revenue Growth (yoy) | -6.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | 1B |
| Net Income Avi to Common (ttm) | 486.79M |
| Diluted EPS (ttm) | 0.0900 |
| Quarterly Earnings Growth (yoy) | -6.40% |
Balance Sheet
| Total Cash (mrq) | 922.05M |
| Total Cash Per Share (mrq) | 1.37 |
| Total Debt (mrq) | 1.32B |
| Total Debt/Equity (mrq) | 26.36% |
| Current Ratio (mrq) | 1.42 |
| Book Value Per Share (mrq) | 7.05 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 487.09M |
| Levered Free Cash Flow (ttm) | 319.04M |
© 2024 Yahoo. All rights reserved.